ridaforolimus

Merck Abandons Once-Promising Experimental Cancer Drug to Ariad
Wall St Cheat Sheet
Tue, 02/25/14 - 06:15 pm
Merck
Ariad Pharmaceuticals
ridaforolimus
FDA Rejection. EU Withdrawal. Set and Match?
Motley Fool
Fri, 11/30/12 - 09:39 am
FDA
Europe
ridaforolimus
Ariad Pharma
Merck
Merck withdraws Marketing Authorisation Application for ridaforolimus in Europe
The Fly on the Wall
Thu, 11/29/12 - 10:40 am
Europe
ridaforolimus
Merck
3 Things to Watch at Ariad Pharmaceuticals
Motley Fool
Tue, 10/16/12 - 10:38 am
Ariad Pharmaceuticals
Ponatinib
ridaforolimus
AP1903
AP26113
Are Ariad's Options Dwindling?
Motley Fool
Sun, 04/1/12 - 12:35 pm
Ariad Pharmaceuticals
ridaforolimus
Merck
GSK
Votrient
Advisory Panel Pans Drug, Investors Shrug?
Motley Fool
Thu, 03/22/12 - 11:09 am
FDA
advisory panels
investors
ridaforolimus
Ariad Pharmaceuticals
Merck
An FDA Advisory Panel Doubleheader
Motley Fool
Tue, 03/20/12 - 10:07 am
FDA
advisory panels
Votrient
soft tissue sarcomas
GSK
Merck
ridaforolimus
Ariad Pharmaceuticals
FDA Staff Questions Benefits of Glaxo, Merck Cancer Drugs
Bloomberg
Fri, 03/16/12 - 11:22 am
GSK
Merck
FDA
Ariad Pharmaceuticals
ridaforolimus
Votrient
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Yahoo/AP
Wed, 10/5/11 - 10:52 am
FDA
sarcoma
ridaforolimus
Merck
Ariad Pharmaceuticals
Merck-Ariad Drug Under EU Review
Yahoo/Zacks
Sat, 08/20/11 - 10:00 pm
Merck
Ariad Pharmaceuticals
ridaforolimus
sarcoma
Ariad advances cancer drug, nabs $25M from partner Merck
Bizjournals.com
Thu, 08/18/11 - 05:35 pm
Ariad Pharmaceuticals
Merck
sarcoma
ridaforolimus
ARIAD shares rise on EU review of potential cancer drug
Bizjournals.com
Mon, 08/1/11 - 12:09 pm
Ariad Pharmaceuticals
EU
Merck
ridaforolimus
Ariad-Merck Cancer Medicine Extends Patients’ Lives in Study
Bloomberg
Mon, 06/6/11 - 09:24 am
Ariad Pharmaceuticals
Merck
ridaforolimus
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thu, 05/12/11 - 11:48 am
Ariad Pharmaceuticals
Exelixis
ridaforolimus
cancer
cabozantinib
Ariad Gains Most in 18 Months on Cancer Drug Results
Bloomberg
Wed, 01/19/11 - 09:07 am
sarcoma
Ariad Pharmaceuticals
ridaforolimus
Ariad Sarcoma Drug Delays Progression
TheStreet.com
Tue, 01/18/11 - 10:47 am
Ariad Pharmaceuticals
sarcoma
ridaforolimus
Ariad Sees Options Interest Boost
Seeking Alpha
Thu, 12/2/10 - 09:36 am
Ariad Pharmaceuticals
options
ridaforolimus
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tue, 11/23/10 - 09:27 am
endometrial cancer
Ariad Pharmaceuticals
Merck
mTOR inhibitors
ridaforolimus
Ariad Pharma cancer drug meets midstage study goal
Yahoo/AP
Mon, 10/25/10 - 10:32 am
Ariad Pharmaceuticals
clinical trials
cancer
ridaforolimus

Pages